Relacorilant CAS No.: 1496510-51-0 – An Overview Of The Chemical Compound
Relacorilant is a chemical substance that has been gaining popularity in recent times for its various health benefits. It is a selective and potent non-steroidal modulator of the glucocorticoid receptor (GR) with anti-inflammatory properties. In this article, we will take a closer look at this chemical compound, including its molecular formula, formula weight, CAS number, synonyms, health benefits, mechanism of action and potential side effects.
Chemical name: 2-chloro-6'-[2,4-dichloro-3-(2-hydroxyethoxy)phenyl]-3,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid Molecular formula: C25H20Cl3NO6 Formula weight: 540.79 g/mol CAS No.: 1496510-51-0
Synonyms:
Top ten keywords from Google:
Health Benefits of Relacorilant: Relacorilant has been studied for its potential therapeutic benefits in various diseases, including Cushing's syndrome, a rare hormonal disorder that results in high levels of cortisol in the body. In clinical trials, Relacorilant has shown promising results in reducing cortisol levels in patients with Cushing's syndrome, leading to improved symptoms such as weight gain, diabetes, and high blood pressure. It has also been beneficial in the treatment of various other inflammatory conditions.
Product Mechanism: Relacorilant works by blocking the action of cortisol, a hormone in the body that causes inflammation and affects the immune system. By blocking cortisol, Relacorilant can reduce inflammation and improve symptoms associated with conditions such as Cushing's syndrome. It is a selective modulator of the glucocorticoid receptor (GR), which is responsible for regulating cortisol levels in the body, and has shown to be a potent inhibitor of this receptor.
Safety: Like any other medication, Relacorilant can cause side effects in some patients. However, the safety profile of Relacorilant appears to be favourable, with most side effects being mild to moderate in severity. The most common side effects reported in clinical trials were nausea, fatigue, and headache. Patients who have liver or kidney problems should consult their doctor before taking this medication.
Side Effects: In clinical trials, the most common side effects of Relacorilant were fatigue, nausea, and headache. Other less common side effects included dizziness, diarrhoea, and abdominal pain. As Relacorilant is still being studied, there is still much to learn about its effects on the body, and patients should report any other side effects they experience to their healthcare provider.
Dosing Information: Relacorilant dosing information should be followed strictly as per the doctor’s prescription. Patients should take the medication exactly as directed and should not stop taking it without consulting their doctor first. The appropriate dosage may vary depending on the patient's age, weight, and other factors.
Conclusion: Relacorilant is a chemical compound that has shown promising therapeutic effects in various inflammatory conditions, especially in patients with Cushing's syndrome. While it has a favourable safety profile, patients should follow their doctor's instructions regarding dosing and avoid stopping the medication unexpectedly. It is a potent anti-inflammatory agent that works by blocking the action of cortisol, which is responsible for regulating inflammation in the body. Relacorilant is still undergoing clinical studies, and patients should consult their doctor to learn more about its potential health benefits before using it for treatment.
